2 findings
“Clinically recognized SLD carried substantially higher all-cause mortality than uncoded SLD”
Associations
23-point major adverse cardiovascular events
upin humans1RR 1.18
1 study
3-point major adverse cardiovascular events
upin humans1RR 1.18
Clinically recognized steatotic liver disease is associated with 3-point major adverse cardiovascular events in humans (Adjusted RR 1.18 (95% CI 0.87–1.59; p=0.29); 10.7% versus 8.9%).
HumansClinically recognized versus clinically uncoded steatotic liver disease in adults with at least one cardiometabolic risk factor; adjusted for demographics and comorbiditiesMedian follow-up 2.2 years
Mortality
upin humans1RR 1.7
1 study
Mortality
upin humans1RR 1.7
Clinically recognized steatotic liver disease is associated with mortality in humans (Adjusted RR 1.70 (95% CI 1.31–2.21); 14.1% versus 9.6%).
HumansClinically recognized versus clinically uncoded steatotic liver disease in adults with at least one cardiometabolic risk factor; adjusted for demographics and comorbiditiesMedian follow-up 2.2 years